Erik Schwiebert

Director, Biotech Accelerator

Erik is a human cell physiologist and pathophysiologist by training. In this new role, Erik has one foot back in academia working with UAB and SR on basic science projects focused on the early stages of drug discovery and the other foot in applied science commercialization of these projects into new ventures seeded by strong therapeutic assets and technologies. Erik has devoted equal portions of his 35-year career to basic and applied science in academia and in applied and translational science in the life sciences and biotechnology industry. He trained at Dartmouth and Johns Hopkins in diseased versus normal human cell signaling with a focus on ion channel and receptor channel function. Erik is excited to be back in early-stage life sciences and biotechnology activities.

Related Articles

Radyus Research Forges Strategic Partnership with Southern Research to Propel Life Sciences Commercialization

March 13, 2024

Radyus Research, a global drug development organization from Atlanta, Georgia, is excited to announce a pivotal strategic partnership with Southern Research, a Birmingham-based contract research organization with more than 80 years of experience in drug discovery and development. This partnership...
Read More

Southern Research opens new Station 41 biotech incubator for startups

January 23, 2024

Today, Southern Research marked the official opening of its Station 41 biotech incubator, which is one of four programs that make up the newly launched Station 41 biotech commercialization hub. The incubator provides wet lab space and office space, shared lab equipment and services to support bio...
Read More

Birmingham receives federal Tech Hub designation and opportunity to apply for millions in federal funding

October 23, 2023

Birmingham’s metro area is among 31 regions across the country named today as a federal Tech Hub, competing successfully under a new program that could ultimately inject $75 million into the local economy. The designation followed a highly competitive process with nearly 200 applications natio...
Read More